Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0BE6M
|
|||
Drug Name |
Anti-Mesothelin CAR-T cells
|
|||
Drug Type |
CAR T Cell Therapy
|
|||
Indication | Gastric adenocarcinoma [ICD-11: 2B72; ICD-9: 151] | Phase 1/2 | [1] | |
Mesothelioma [ICD-11: 2C51.2; ICD-10: C45; ICD-9: 163] | Phase 1/2 | [1] | ||
Pancreatic cancer [ICD-11: 2C10] | Phase 1/2 | [1] | ||
Company |
Shenzhen BinDeBio Ltd.
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Mesothelin (MSLN) | Target Info | CAR-T-Cell-Therapy | [1] |
NetPath Pathway | TCR Signaling Pathway |
References | Top | |||
---|---|---|---|---|
REF 1 | ClinicalTrials.gov (NCT03638206) Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.